Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Gregor, Brecl Jakob"'
Publikováno v:
Zdravniški Vestnik, Vol 93, Iss 9-10, Pp 313-328 (2024)
Multipla skleroza (MS) je kronična, vnetna in demielinizacijska bolezen osrednjega živčevja, ki predstavlja drugi najpogostejši vzrok invalidnosti pri populaciji med 20. in 40. letom starosti. Farmakoterapija MS obsega starejša parenteralna inje
Externí odkaz:
https://doaj.org/article/98f6412ae3554fa08fbaa6507658928b
Autor:
Nevin John, Steve Vucic, Riadh Gouider, Tomas Kalincik, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Serkan Ozakbas, Jeannette Lechner-Scott, Cavit Boz, Julie Prevost, Recai Turkoglu, Vincent Van Pesch, Cristina Ramo-Tello, Mark Slee, Raed Alroughani, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Suzanne Hodgkinson, Rana Karabudak, Tim Spelman, Helmut Butzkueven, Noriko Isobe, Paul G Sanfilippo, Michael Barnett, Orla Gray, Maria José Sá, Allan Kermode, Guy Laureys, Richard Macdonell, Anneke Van Der Walt, Ayse Altintas, Mario Habek, Pamela McCombe, Seyed Mohammad Baghbanian, Yi Chao Foong, Riki Matsumoto, Abdullah Al-Asmi, Bruce Taylor, Samia J Khoury, Todd Hardy, Katherine Buzzard, Marzena Fabis-Pedrini, Louise Rath, Olga Skibina, Jiwon Oh, William M Carroll, Katrin Gross-Paju, Jan Schepel, Sara Eichau, Elisabetta Cartechini, Aysun Soysal, Davide Maimone, Anoushka Lal, Masoud Etemadifar, Oliver Gerlach, Saloua Mrabet, Emanuele D'Amico, Yolanda Blanco, Matteo Foschi, Melissa Cambron, Andrea Surcinelli, David Levitz, Liesbeth Van Hijfte, Mehmet Fatih Yetkin, Simón Cárdenas-Robledo, Emmanuelle Lapointe, Abdorreza Naser Moghadasi, Gregor Brecl Jakob, Talal Al-Harbi
Publikováno v:
BMJ Neurology Open, Vol 6, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/fc8e0655ceeb42e4b6966e9c79930d0b
Autor:
Maj Jožef, Igor Locatelli, Gregor Brecl Jakob, Lina Savšek, Katarina Šurlan Popovič, Žiga Špiclin, Uroš Rot, Mitja Kos
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/747053e6074345b39c494189bde9f9ee
Autor:
Nik Krajnc, Gregor Brecl Jakob
Publikováno v:
Zdravniški Vestnik, Vol 90, Iss 11-12, Pp 628-636 (2021)
Vaskulitisi so redka in raznolika skupina bolezni, ki prizadenejo male, srednje velike in/ali velike žile. Večinoma gre za sistemske bolezni, vendar lahko v redkih primerih prizadenejo samo žilje v osrednjem živčevju; tedaj jih imenujemo primarn
Externí odkaz:
https://doaj.org/article/229a70d81a51427da82cc6089217d51d
Autor:
Mario Habek, Jelena Drulovic, Gregor Brecl Jakob, Ivan Barbov, Ljiljana Radulovic, Cecilia Rajda, Konrad Rejdak, Peter Turčáni
Publikováno v:
Neurology and Therapy. 12:25-37
Based on the results of the pivotal CLARITY study, cladribine tablets were approved for use in the European Union in 2017 as a high-efficacy therapy for highly active relapsing-remitting multiple sclerosis (MS). Cladribine tablets are used as an indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::751acf92f383b297645383dd1750a220
https://doi.org/10.1007/s40120-022-00422-z
https://doi.org/10.1007/s40120-022-00422-z
Autor:
Mario Habek, Marko Andabaka, Alessandra Fanciulli, Gregor Brecl Jakob, Jelena Drulović, Fabian Leys, Franziska Di Pauli, Harald Hegen, Michael Auer, Tatjana Pekmezović, Šarlota Mesaroš, Vanja Jovičević, Anamari Junaković, Gregor K. Wenning, Florian Deisenhammer, Tereza Gabelić, Barbara Barun, Ivan Adamec, Magdalena Krbot Skorić
Publikováno v:
European Journal of Neurology. 29:2772-2780
Background and purpose: The aim was to determine the extent of sudomotor dysfunction in people with neuromyelitis optica spectrum disorder (pwNMOSD) and to compare findings with a historical cohort of people with relapsing-remitting multiple sclerosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f46d55cc18c83dbe3e43b281684959
https://doi.org/10.1111/ene.15413
https://doi.org/10.1111/ene.15413
Publikováno v:
Medical Imaging 2023: Computer-Aided Diagnosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d37ccbb180adde0ad601985a52623cb5
https://doi.org/10.1117/12.2654416
https://doi.org/10.1117/12.2654416
Autor:
Gregor Brecl Jakob, Nik Krajnc
Publikováno v:
Zdravniški Vestnik, Vol 90, Iss 11-12, Pp 628-636 (2021)
Vaskulitisi so redka in raznolika skupina bolezni, ki prizadenejo male, srednje velike in/ali velike žile. Večinoma gre za sistemske bolezni, vendar lahko v redkih primerih prizadenejo samo žilje v osrednjem živčevju; tedaj jih imenujemo primarn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc672a7f3a974987f6284c0f8ee711a1
https://vestnik.szd.si/index.php/ZdravVest/article/view/3092
https://vestnik.szd.si/index.php/ZdravVest/article/view/3092
Publikováno v:
Neurological Sciences. 43:3509-3511
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757b57b51b2a61ccb250bccd4bc8d444
https://doi.org/10.1007/s10072-022-05966-4
https://doi.org/10.1007/s10072-022-05966-4
Autor:
Magdalena Krbot Skorić, Mario Habek, Saša Šega Jazbec, Gregor Brecl Jakob, Sarah Gomezelj, Tereza Gabelić, Ivan Adamec, Alenka Horvat Ledinek, Uroš Rot, Barbara Barun
Publikováno v:
Neurological Sciences. 42:4591-4597
Objective: So far, a limited number of real-world evidence studies about the effectiveness and safety of alemtuzumab (ALM) have been published, some of them with a relatively small number of included patients. We aimed to study the efficacy and safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95a6b5b9ada37db337fa0ecd31f5e34
https://doi.org/10.1007/s10072-021-05145-x
https://doi.org/10.1007/s10072-021-05145-x